Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 4
2006 1
2008 1
2012 1
2013 4
2015 1
2016 2
2017 2
2018 2
2019 3
2020 4
2021 4
2022 7
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer.
Yamazoe M, Ozasa H, Tsuji T, Funazo T, Yoshida H, Hashimoto K, Hosoya K, Ogimoto T, Ajimizu H, Yoshida H, Itotani R, Sakamori Y, Kuninaga K, Aoki W, Hirai T. Yamazoe M, et al. Among authors: hashimoto k. Cancer Sci. 2023 Feb;114(2):546-560. doi: 10.1111/cas.15622. Epub 2022 Nov 23. Cancer Sci. 2023. PMID: 36285485 Free PMC article.
Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung Cancer.
Ogimoto T, Ozasa H, Tsuji T, Funazo T, Yamazoe M, Hashimoto K, Yoshida H, Hosoya K, Ajimizu H, Nomizo T, Yoshida H, Hamaji M, Menju T, Yoshizawa A, Date H, Hirai T. Ogimoto T, et al. Among authors: hashimoto k. Mol Cancer Ther. 2024 Apr 2;23(4):564-576. doi: 10.1158/1535-7163.MCT-23-0371. Mol Cancer Ther. 2024. PMID: 38052760
Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy-induced colitis.
Sakurai T, De Velasco MA, Sakai K, Nagai T, Nishiyama H, Hashimoto K, Uemura H, Kawakami H, Nakagawa K, Ogata H, Nishio K, Kudo M. Sakurai T, et al. Among authors: hashimoto k. Mol Oncol. 2022 Apr;16(7):1493-1507. doi: 10.1002/1878-0261.13062. Epub 2021 Jul 28. Mol Oncol. 2022. PMID: 34270845 Free PMC article.
Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity.
Kataoka Y, Tanabe N, Shirata M, Hamao N, Oi I, Maetani T, Shiraishi Y, Hashimoto K, Yamazoe M, Shima H, Ajimizu H, Oguma T, Emura M, Endo K, Hasegawa Y, Mio T, Shiota T, Yasui H, Nakaji H, Tsuchiya M, Tomii K, Hirai T, Ito I. Kataoka Y, et al. Among authors: hashimoto k. Respir Res. 2024 Jan 10;25(1):24. doi: 10.1186/s12931-024-02673-w. Respir Res. 2024. PMID: 38200566 Free PMC article.
37 results